|
| |
Mandip Sachdeva, Ph.D., a professor and section leader for the pharmaceutics activity in the College of Pharmacy and Pharmaceutical Sciences, has secured more $25 million in grant funding from agencies such as the National Institutes of Health, NASA, the U.S. Department of Defense and various pharmaceutical companies. He is hopeful that his research will lead to novel and targeted treatment methods for lung cancer and skin inflammatory disorders.
He has made significant contributions to the knowledge and understanding in the area of drug delivery with special emphasis in inhalation/aerosol delivery as applied to lung cancer and topical delivery of neuropeptides. He has used a multidisciplinary approach of not only delivering novel anticancer agents by inhalation drug delivery, but also looked into their mechanism of action to look for newer targets.
His research emphasis has also been to understand neurogenic skin inflammation and investigate into topical delivery of peptides. During the last 20 years, besides developing new approaches for improved drug delivery to the lungs and through the skin, Sachdeva has identified new molecular pathways and mechanisms for therapeutic agents intended for the treatment of lung cancer and skin inflammation. He has also made significant contribution in understanding skin irritation and to use in situ methods like skin microdialysis to look for various markers for skin irritation in the skin. His work has resulted in more than 90 peer reviewed publications, six book chapters and more than 150 presentations in national and international meetings. He has been the editor-in-chief of CRC Critical Reviews in Therapeutic Drug Carrier Systems since 2007. In 2010, he was a recipient of the FAMU Research Excellence Award.
Sachdeva received his bachelor of science degree in pharmacy from Panjab University, India in 1980. He earned his master’s and Ph.D. degrees in bio-pharmaceutics from Dalhousie University, Halifax, Nova Scotia, Canada in 1986 and 1989 respectively. He then worked for a pharmaceutical company, SynPhar Laboratories in Edmonton, in Alberta, Canada for four years as a group leader for drug targeting. He joined FAMU as an assistant professor in 1993 and was promoted to associate professor in 1996 and professor in 2002. During his tenure at FAMU, Sachdeva was instrumental in developing the graduate program in pharmaceutics.
|
|
|
